Sector Chart BioCryst Pharmaceuticals, Inc.

Stocks

BCRX

US09058V1035

Biotechnology & Medical Research

Market Closed - Nasdaq 16:00:00 2026-06-26 EDT 5-day change 1st Jan Change
9.940 USD +0.40% Intraday chart for BioCryst Pharmaceuticals, Inc. +10.57% +27.44%
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales Growth Profitability Finances EV / Sales P/E
2.53B - - -
55.63B
52.25B
23.07B -
22.41B -
17.32B